<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ketendo</journal-id><journal-title-group><journal-title xml:lang="ru">Клиническая и экспериментальная тиреоидология</journal-title><trans-title-group xml:lang="en"><trans-title>Clinical and experimental thyroidology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-5472</issn><issn pub-type="epub">2310-3787</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/ket20106342-47</article-id><article-id custom-type="elpub" pub-id-type="custom">ketendo-4282</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Состояние метаболизма лимфоцитов крови у больных диффузным токсическим зобом в процессе лечения</article-title><trans-title-group xml:lang="en"><trans-title>The state of blood lymphocyte metabolism in Graves' disease patients in the treatment course</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Shagarova</surname><given-names>S G</given-names></name></name-alternatives><email xlink:type="simple">sv528@mail.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Macinina</surname><given-names>V P</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Dogadin</surname><given-names>S A</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Savchenko</surname><given-names>A A</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Manchuk</surname><given-names>V T</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>15</day><month>09</month><year>2010</year></pub-date><volume>6</volume><issue>3</issue><issue-title>ТОМ 6, №3 (2010)</issue-title><fpage>42</fpage><lpage>47</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Shagarova S.G., Macinina V.P., Dogadin S.A., Savchenko A.A., Manchuk V.T., 2010</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="ru">Shagarova S.G., Macinina V.P., Dogadin S.A., Savchenko A.A., Manchuk V.T.</copyright-holder><copyright-holder xml:lang="en">Shagarova S.G., Macinina V.P., Dogadin S.A., Savchenko A.A., Manchuk V.T.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.cet-endojournals.ru/jour/article/view/4282">https://www.cet-endojournals.ru/jour/article/view/4282</self-uri><abstract><p>В статье представлены данные исследования метаболизма лимфоцитов крови 35 женщин с болезнью Грейвса. Определе1 ние содержания тиреоидных (св. Т4 и св. Т3) и тиреотропного гормонов, антител к тиреопероксидазе и активности НАД(Ф)1зависимых дегидрогеназ лимфоцитов крови проводилось до начала лечения и спустя 1 и 3 мес на фоне приема тимазола. В течение 3 мес терапии больных болезнью Грейвса достигается нормализация функции ЩЖ. В процессе ле1 чения женщин с БГ метаболизм лимфоцитов на протяжении всего периода наблюдения характеризуется повышенным уровнем макромолекулярного синтеза и антиоксидантной способности клеток, высокой эффективностью малат1аспар1 татной челночной системы, а также повышенным уровнем аминокислотного обмена. Также у больных болезнью Грейвса нарушена эндокринная регуляции метаболизма лимфоцитов, на что указывает уменьшение взаимосвязанности между концентрацией тиреоидных гормонов и ферментативными показателями.</p></abstract><trans-abstract xml:lang="en"><p>This article is about the research of the blood lymphocyte metabolism in 35 women with Graves' disease (GD). The definition of thyroid (fO4, O3), thyro1tropic hormones, antibodies against thyroid peroxidase and blood lymphocyte NAD(P)1dependent dehydrogenases was spent before the beginning of treatment and later 1 and 3 months receip1 tion of thiamazolc. The thyroid hormones concen1tration in GD patients is come to normal after 3 months of treat1 ment. The lympho1cyte metabolism is characterized by the increase level of macromolecular synthesis and antiox1 idant ability in cells, high efficiency malate1aspartate shuttle, and the increase level amino1acid exchange in GD patients throughout all period of re1search. Also in GD patients it is broken endocrine regulation of lymphocyte me1 tabolism, one point the correlation reduction between thyroid hormones concentra1tion and enzyme indicators.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>диффузный токсический зоб</kwd><kwd>метаболизм</kwd><kwd>лимфоцит</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Graves' disease</kwd><kwd>metabolism</kwd><kwd>lymphocyte</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Березов Т.Т., Коровкин Б.Ф. Биологическая химия. М.: Медицина, 1998.</mixed-citation><mixed-citation xml:lang="en">Березов Т.Т., Коровкин Б.Ф. Биологическая химия. М.: Медицина, 1998.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Захарова Л.Б., Манчук В.Т., Нагирная Л.А. Метаболизм иммунокомпетентных клеток жителей Севера в онтогенезе. Новосибирск, 1999.</mixed-citation><mixed-citation xml:lang="en">Захарова Л.Б., Манчук В.Т., Нагирная Л.А. Метаболизм иммунокомпетентных клеток жителей Севера в онтогенезе. Новосибирск, 1999.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Иванищев В.В., Курганов Б.И. Ферменты метаболизма малата: характеристика, регуляция активности и биологическая роль // Биохимия. 1992. Т. 57. Вып. 5. С.6 53–662.</mixed-citation><mixed-citation xml:lang="en">Иванищев В.В., Курганов Б.И. Ферменты метаболизма малата: характеристика, регуляция активности и биологическая роль // Биохимия. 1992. Т. 57. Вып. 5. С.6 53–662.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Колода Д.Е., Фадеев В.В. Антитела к рецептору тиреотропного гормона в диагностике и лечении болезни Грейвса–Базедова // Пробл. эндокринол. 2005. №2. С. 8–14.</mixed-citation><mixed-citation xml:lang="en">Колода Д.Е., Фадеев В.В. Антитела к рецептору тиреотропного гормона в диагностике и лечении болезни Грейвса–Базедова // Пробл. эндокринол. 2005. №2. С. 8–14.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Робинсон М.В., Торопова Л.Б., Труфакин В.А. Морфология и метаболизм лимфоцитов. Новосибирск: Наука, 1986.</mixed-citation><mixed-citation xml:lang="en">Робинсон М.В., Торопова Л.Б., Труфакин В.А. Морфология и метаболизм лимфоцитов. Новосибирск: Наука, 1986.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Савченко А.А., Кадричева С.Г., Догадин С.А., Бураков А.Ю. Информативность показателей активности ферментов лимфоцитов у больных аутоиммунными заболеваниями щитовидной железы // Пробл. эндокринологии. 2003. Т. 49. №3. С. 18–22.</mixed-citation><mixed-citation xml:lang="en">Савченко А.А., Кадричева С.Г., Догадин С.А., Бураков А.Ю. Информативность показателей активности ферментов лимфоцитов у больных аутоиммунными заболеваниями щитовидной железы // Пробл. эндокринологии. 2003. Т. 49. №3. С. 18–22.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Савченко А.А., Сунцова Л.Н. Высокочувствительное определение активности дегидрогеназ в лимфоцитах периферической крови человека биолюминесцентным методом // Лаб. дело. 1989. №11. С. 23–25.</mixed-citation><mixed-citation xml:lang="en">Савченко А.А., Сунцова Л.Н. Высокочувствительное определение активности дегидрогеназ в лимфоцитах периферической крови человека биолюминесцентным методом // Лаб. дело. 1989. №11. С. 23–25.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Фадеев В.В. Болезнь Грейвса // Рус. мед. жур. 2002. Т. 10. №27. С. 1262–1265.</mixed-citation><mixed-citation xml:lang="en">Фадеев В.В. Болезнь Грейвса // Рус. мед. жур. 2002. Т. 10. №27. С. 1262–1265.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Эндокринология. Национальное руководство / Под ред. Дедова И.И. М.: ГЭОТАР-Медиа, 2008.</mixed-citation><mixed-citation xml:lang="en">Эндокринология. Национальное руководство / Под ред. Дедова И.И. М.: ГЭОТАР-Медиа, 2008.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Alnaqdy A., Al Maskari M. Determination of the levels of anti1thyroid-stimulating hormone receptor antibody with thyroid peroxidase antibody in Omani patients with Graves’ disease // Med. Princ. Pract. 2005. V. 14. N4. P. 209–212.</mixed-citation><mixed-citation xml:lang="en">Alnaqdy A., Al Maskari M. Determination of the levels of anti1thyroid-stimulating hormone receptor antibody with thyroid peroxidase antibody in Omani patients with Graves’ disease // Med. Princ. Pract. 2005. V. 14. N4. P. 209–212.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Board M., Humm S., Newsholme E.A. Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells // Biochem J. 1990. V. 265. N2. P. 503–509.</mixed-citation><mixed-citation xml:lang="en">Board M., Humm S., Newsholme E.A. Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells // Biochem J. 1990. V. 265. N2. P. 503–509.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bortell R., Moss J., McKenna R.C. et al. Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: role of cell surface NAD glycohydrolase and pyrophos1 phatase activities // J. Immunol. 2001. V. 167. N4. P. 2049–2059.</mixed-citation><mixed-citation xml:lang="en">Bortell R., Moss J., McKenna R.C. et al. Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: role of cell surface NAD glycohydrolase and pyrophos1 phatase activities // J. Immunol. 2001. V. 167. N4. P. 2049–2059.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dogan R.N.E., Vasu C., Holterman M.J., Prabhakar B.S. Absence of IL14, and Not Suppression of the Th2 Response, Prevents Development of Experimental Autoimmune Graves’ Disease // J. Immunol. 2003. V. 170. P. 2195–2204.</mixed-citation><mixed-citation xml:lang="en">Dogan R.N.E., Vasu C., Holterman M.J., Prabhakar B.S. Absence of IL14, and Not Suppression of the Th2 Response, Prevents Development of Experimental Autoimmune Graves’ Disease // J. Immunol. 2003. V. 170. P. 2195–2204.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hwang K., Jeong D.W., Lee J.W. et al. Alteration of the NAD+/NADH ratio in CHO cells by stable transfection with human cytosolic glycerol-3-phosphate dehydrogenase: resistance to oxidative stress // Mol. Cells. 1999. V. 9. N4. P. 429–435.</mixed-citation><mixed-citation xml:lang="en">Hwang K., Jeong D.W., Lee J.W. et al. Alteration of the NAD+/NADH ratio in CHO cells by stable transfection with human cytosolic glycerol-3-phosphate dehydrogenase: resistance to oxidative stress // Mol. Cells. 1999. V. 9. N4. P. 429–435.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Rapoport B., McLachlan S.M. Thyroid autoimmunity // J. Clin. Invest. 2001. V. 108. N9. Р. 1253–1259.</mixed-citation><mixed-citation xml:lang="en">Rapoport B., McLachlan S.M. Thyroid autoimmunity // J. Clin. Invest. 2001. V. 108. N9. Р. 1253–1259.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Tarrío N., García Leiro A., Cerdán M.E. et al. The role of glutathione reductase in the interplay between oxidative stress response and turnover of cytosolic NADPH in Kluyveromyces lactis // FEMS Yeast Res. 2008. V. 8. N4. Р. 597–606.</mixed-citation><mixed-citation xml:lang="en">Tarrío N., García Leiro A., Cerdán M.E. et al. The role of glutathione reductase in the interplay between oxidative stress response and turnover of cytosolic NADPH in Kluyveromyces lactis // FEMS Yeast Res. 2008. V. 8. N4. Р. 597–606.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Volpe R. Autoimmune diseases of the endocrine system / CRC. Boca Raton, 1999. Р. 51–72.</mixed-citation><mixed-citation xml:lang="en">Volpe R. Autoimmune diseases of the endocrine system / CRC. Boca Raton, 1999. Р. 51–72.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Yamauchi M., Kambe F., Cao X. et al. Thyroid hormone activates adenosine 5’1monophosphate-activated protein kinase via intracellular calcium mobilization and activation of calcium/calmodulin-dependent protein kinase kinase-beta // Mol. Endocrinol. 2008. V. 22. N4. Р.893–903.</mixed-citation><mixed-citation xml:lang="en">Yamauchi M., Kambe F., Cao X. et al. Thyroid hormone activates adenosine 5’1monophosphate-activated protein kinase via intracellular calcium mobilization and activation of calcium/calmodulin-dependent protein kinase kinase-beta // Mol. Endocrinol. 2008. V. 22. N4. Р.893–903.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
